At the time of writing, enVVeno Medical Corporation [NVNO] stock is trading at $0.97, up 2.15%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVNO shares have gain 8.75% over the last week, with a monthly amount glided 0.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of enVVeno Medical Corporation fluctuated between $0.67 and $5.62. enVVeno Medical Corporation [NASDAQ: NVNO] shares were valued at $0.97 at the most recent close of the market.
Analyzing the NVNO fundamentals
Gross Profit Margin for this corporation currently stands at 0.03% with Operating Profit Margin at -30.63%, Pretax Profit Margin comes in at -28.41%, and Net Profit Margin reading is -28.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -0.57 and Total Capital is -0.74. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9435 points at the first support level, and at 0.9127 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0125, and for the 2nd resistance point, it is at 1.0507.
Ratios To Look Out For
It is important to note that enVVeno Medical Corporation [NASDAQ:NVNO] has a current ratio of 11.81. Also, the Quick Ratio is 11.81, while the Cash Ratio stands at 0.68.
Transactions by insiders
Recent insider trading involved Duhay Francis, Director, that happened on Sep 15 ’25 when 4900.0 shares were sold. Director, Duhay Francis completed a deal on Sep 15 ’25 to buy 9800.0 shares. Meanwhile, Director Duhay Francis bought 81433.0 shares on Dec 31 ’24.
